SNX29 expression was positively associated with CD4 memory T-cell activation in CHOL and PAAD but negatively related with CD4 memory T-cell activation in KIRC, LUAD, COAD, KIRP, READ, CESC and HNSC. Here, SNX29 is linked to pancreatic adenocarcinoma.